Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Redefining “Community”: From Niche to Next-Generation Performance and Scale

November 10, 2025

Discover how 1P data and a powerful tech stack prove that patient communities can deliver unrivaled quality and massive scale.

Building Authentic Connections: The Core of Health Union’s Community Model

October 30, 2025

What sets Health Union’s model apart? Learn how expert community managers and peer-to-peer validation build the confidence patients need to take action in their health journey.

Maximize Your Programmatic Reach: The Power of Audience Diversification

October 16, 2025

Maximize programmatic reach by diversifying your audience strategy. Learn how utilizing partners with differentiated data and granular segmentation unlocks net-new, high-intent audiences to connect with patients at critical decision points. Discover how Health Union delivers superior Audience Quality Index performance

Innovation in Action: Leveraging KOLs and AI for Unrivaled Brand Advocacy

October 14, 2025

HCPs trust their peers more than anyone, but they're also busier than ever. Learn how to leverage the credibility of KOLs and the power of AI to deliver vital information.

IBS Patient-Reported Survey Data 2020

October 19, 2020

Merely 9% of people living with IBS were currently taking a prescription IBS medication, according to new Health Union patient-reported survey data.

Alzheimer’s Disease Patient-Reported Survey Data | 2020

October 6, 2020

Only 11% of people living with Alzheimer’s disease feel controlled on their current treatment plan, according to Health Union patient-reported survey data.

COPD Patient-Reported Survey Data | 2020

September 23, 2020

44% of people living with COPD who experience pain consider themselves as having chronic pain, according to new Health Union survey data.

Multiple Sclerosis Patient-Reported Survey Data | 2020

September 10, 2020

71% of people living with multiple sclerosis currently use a DMT but many live with pain and emotional grief, according to new Health Union survey data.

Healthcare Industry Thought Leadership

Contact